Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim vs Filgrastim after High-Dose Chemotherapy
NCT00410696Phase 2Completed
- Sponsor
- Armando Santoro
- Start
- Sep 2006
- Primary completion
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in chemotherapy-induced neutropenia (CIN), sponsored by Armando Santoro. Started Sep 2006; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on NCT00410696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410696.